Prevalence, genetic variants, and clinical implications of hypocholesterolemia in children

Atherosclerosis. 2025 Jan:400:119065. doi: 10.1016/j.atherosclerosis.2024.119065. Epub 2024 Nov 22.

Abstract

Background and aims: In contrast to extensively studied hypercholesterolemia, knowledge of hypocholesterolemia is limited. This study aims to assess the prevalence, clinical characteristics, and genetics of children and adolescents with hypocholesterolemia.

Methods: This national prospective cross-sectional cohort study was part of Slovenia's universal opt-out cholesterol screening program. The first part assessed hypocholesterolemia prevalence among 3538 children aged 5 years, randomly selected at the mandatory check-up. The second part included analysis of demographic and clinical data and genetic testing of 71 individuals with suspected hypocholesterolemia (total cholesterol [TC] < 3.0 mmol/L [116.0 mg/dL]) referred to the Lipid Clinic of University Children's Hospital Ljubljana.

Results: The prevalence of hypocholesterolemia among 3538 children was 2.66 % (95 % CI: 2.13-3.19 %). Among the 71 genetically tested individuals with suspected hypocholesterolemia, those with pathogenic variants had lower TC (2.58 ± 0.44 mmol/L vs. 2.85 ± 0.42 mmol/L [99.77 ± 17.02 mg/dL vs. 110.20 ± 16.24 mg/dL]; p = 0.037) and low-density lipoprotein cholesterol (1.00 ± 0.40 mmol/L vs. 1.33 ± 0.40 mmol/L [38.67 ± 15.47 mg/dL vs. 51.43 ± 15.47 mg/dL]; p = 0.014) compared to those without such variants. Genetic testing identified pathogenic alterations in 15 subjects, including 4 novel loss-of-function variants in the APOB gene. All but one subject were asymptomatic.

Conclusions: This study provides new clinical and genetic insights into hypocholesterolemia. Asymptomatic patients with hypocholesterolemia may not require further evaluation, but additional research is needed to understand hypocholesterolemia better.

Keywords: APOB; Children; Hypocholesterolemia; Next-generation sequencing; Prevalence.

MeSH terms

  • Adolescent
  • Age Factors
  • Apolipoprotein B-100 / blood
  • Apolipoprotein B-100 / genetics
  • Biomarkers / blood
  • Child
  • Child, Preschool
  • Cholesterol* / blood
  • Cholesterol, LDL / blood
  • Cross-Sectional Studies
  • Female
  • Genetic Predisposition to Disease
  • Genetic Testing / methods
  • Humans
  • Hypercholesterolemia / blood
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / epidemiology
  • Hypercholesterolemia / genetics
  • Male
  • Mutation
  • Phenotype
  • Prevalence
  • Proprotein Convertase 9 / genetics
  • Prospective Studies
  • Risk Factors
  • Slovenia / epidemiology

Substances

  • APOB protein, human
  • Cholesterol
  • Apolipoprotein B-100
  • Biomarkers
  • PCSK9 protein, human
  • Proprotein Convertase 9
  • Cholesterol, LDL